Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.
Where Biogen Stands With Analysts
20 analysts have shared their evaluations of Biogen (NASDAQ:BIIB) during the recent three months, expressing a mix of…
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Looking Into Biogen’s Recent Short Interest
Biogen’s (NYSE:BIIB) short percent of float has fallen 5.07% since its last report. The company recently reported that…
Peering Into Biogen’s Recent Short Interest
Biogen’s (NYSE:BIIB) short percent of float has fallen 18.77% since its last report. The company recently reported that…
Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says
Biogen's Leqembi launch challenges impact stock growth; Spinraza faces competition. Analyst lowers price target to $316, citing uncertainties.
Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Markets Tumble, VIX Up 8% On Hot Inflation Data, Dollar, Yields Jump As Traders Unwind Rate Cut Bets: What’s Driving Markets Tuesday?
Wall Street witnessed one of the worst sessions since the beginning of the year, with widespread declines across the board as stocks were hit by the impact of a higher-than-expected inflation report.
Why Is Biogen Stock Trading Lower On Tuesday?
Biogen's Q4 2023 performance, with $2.39 billion in sales, adjusted EPS of $2.95, and updates on key drugs.
Breaking Down Biogen: 8 Analysts Share Their Views
Across the recent three months, 8 analysts have shared their insights on Biogen (NASDAQ:BIIB), expressing a variety of…